Home > Supplier > Bioline > Bioline – Cloning > Polymerases and PCR mixes > ACCUZYME DNA Polymerase


A robust, efficient, proofreading enzyme that gives increased fidelity in high-yield PCR, for use in all routine cloning applications.

Product Highlights

  • Efficient – highly productive target amplification and removal of 3’ A overhangs
  • Accurate – possesses 3’ – 5’ proofreading exonuclease activity that delivers an error rate of 3.0 x 10-6 for increased PCR fidelity versus Taq DNA polymerase
  • Sensitive – high-yield amplification from limiting amounts of human, animal and plant template DNA
  • Robust – developed for reliable amplification of even the most challenging targets, including genomic DNA and GC-rich targets
  • Flexible – ideal for amplifying any target up to 5 kb from DNA extracted from mammalian tissue samples
  • Convenient – advanced buffering system minimizes the requirements for PCR optimization, thereby reducing time-to-results and eliminating the cost of unnecessary repeats

Product description

ACCUZYME™ is a proprietary proofreading enzyme that offers increased-fidelity and high PCR yield, even in demanding applications. ACCUZYME has an error-rate of 3.0 x 10-6 and results in blunt-ended amplicons up to 5 kb in length, making it ideal for use in cloning and site-directed mutagenesis.

ACCUZYME is supplied with a buffering system that provides ideal conditions for most PCR assays. Consequently, the cost and effort typically associated with optimizing assay performance is often eliminated. In circumstances where further optimization is required to improve PCR specificity and/or yield, ACCUZYME includes an additional vial of MgCl2.


  • High-fidelity PCR
  • Routine cloning applications requiring increased PCR yield
  • Blunt-end cloning
  • Site-directed mutagenesis
SKU:  Size: Webshop:
BIO-21052 500 Units Order online


Request more information

Contact Us

Please fill out the following form about your inquiry.

Cookie notice

Our website uses cookies to improve the user experience, by continuing your visit to our site you agree to our usage of said  cookies.